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Abstract Gene expression of IGF-I, IGFBP-4 and IGFBP-5
was studied in hindhimb skeletal muscle of mice, which were
either overloaded or unloaded for 8 days. Overloading induced a
15% hypertrophy in soleus muscle associated with a 60%
increase of IGF-I transcript levels and a doubling of IGFBP-4
mRNA levels. IGFBP-5 mRNA levels were decreased to one
third of the control value. Changes in IGFBPs mRNA always
preceded changes in IGF-I gene expression. Unloading by
hindlimb suspension resulted in atrophy of soleus muscle (20%)
and phenotype change towards the fast type associated with a
transient decrease of IGF-I mRNA (30%) and a sustained
increase (U2) of IGFBP-5 transcript. These alterations in
IGFBPs expression, in unloaded or overloaded soleus, suggest
that they may play a role in skeletal muscle adaptation to
changes in loading.
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1. Introduction
Skeletal muscle is able to adapt to several external stimuli
such as pattern of nerve or electrical stimulation, hormonal
impregnation, stretch and changes in mechanical loading. In-
creased loading not only induces muscle hypertrophy but also
phenotype changes towards the slow type whereas unloading
is responsible for muscle atrophy and shift from slow to fast
¢ber.
Investigations of the signalling mechanisms involved in
these processes suggest that insulin-like growth factor I
(IGF-I) plays a major role in triggering hypertrophy induced
by overload. First, stretch or overload of skeletal muscle in-
duces an increase in local expression of IGF-I (mRNA and
peptide) which is correlated with muscle hypertrophy, in-
creased protein and DNA contents [1^4]. Second, local infu-
sion or overexpression of IGF-I in skeletal muscle induces
hypertrophy without any systemic e¡ect [5,6].
While the chain of events triggering hypertrophy clearly
involves IGF-I, the signalling mechanism inducing phenotype
change is less clear. First, in individual ¢bers of stretched
skeletal muscle, expression of IGF-I is correlated to that of
slow or neonatal myosin [7]. Second, overexpression of IGF-I
in vivo induces a shift in myo¢ber type towards a more oxi-
dative ¢ber type [5]. Third, soleus muscles of growth hormone
(GH)-de¢cient rats, which are lacking IGF-I, contain higher
proportions of fast ¢bers than muscles from intact rats. Fur-
thermore, treating these rats with GH increases the propor-
tion of slow ¢bers in these muscles [8]. All together, these data
suggest a possible role of IGF-I in fast to slow phenotype
change.
The biological e¡ects of IGF-I on muscle cells have mainly
been studied in vitro. First, IGF-I not only induces myo¢ber
hypertrophy [9] but also a phenotype change [10,11]. Second,
both IGF-I and IGF-II stimulate proliferation and di¡eren-
tiation of myoblasts and the e¡ects of IGFs are modulated
by their binding proteins (IGFBPs) [12]. Amongst the
seven IGFBPs described so far [12,13], four (IGFBP-2, -4,
-5 and -6) are produced by di¡erent myoblast cell lines where-
as only IGFBP-4, IGFBP-5 and IGFBP-6 are expressed by
adult skeletal muscle [12,14]. IGFBP-4 is believed to inhibit
proliferation and di¡erentiation induced by IGF-I whereas
IGFBP-5 has a dual role: inhibition of both processes, or
stimulation of di¡erentiation, depending on culture conditions
[15,12,16].
The potential role of IGFBPs in the physiological response
to loading changes has not yet been investigated. The goal of
the present study was to analyze the regulation of gene ex-
pression of IGF-I and its main IGFBPs in skeletal muscle
subjected to either functional overload or unloading.
2. Materials and methods
2.1. Animals manipulation
Male NMRI mice, 60 days of age at the beginning of the protocol,
were used. The mice were housed in cages, maintained in light con-
trolled environment (12:12-h light-dark cycle) and had unlimited ac-
cess to food and water. Two separate sets of experiments were made:
one for overloading and one for unloading. In each case, the mice
were randomly assigned to two groups: control and treated. All pro-
cedures were performed while the animals were anaesthetized by sub-
cutaneous injection of ketamine (100 mg/kg) and xylazine (10 mg/kg).
Overload was induced by inserting blocks of lead embedded in
silicone underneath the skin of the hinder part of the back [17]. After
a short medial incision in the skin and cutaneous detachment, four
blocks, weighing together about 60% of body weight, were inserted,
two on each side. Mice of the control group received the same treat-
ment except that only silicone blocks weighing about 1.5 gram were
inserted. A group of mice, which did not receive any treatment, served
as a control at day 0 and their muscles were dissected at the beginning
of the experiment.
A modi¢ed version of the protocol described by Criswell [18] was
used to perform hindlimb unloading. A strip of adhesive bandage and
a non-adhesive tape cut 15 cmU0.5 cm were used. The bandages were
wrapped around the tail starting at the base of the tail. After recovery
from anesthesia, a swivel hook was placed through the non-adhesive
bandage, the tips of which were joined. The swivel hook was then
raised so that the hindlimbs were elevated just of the cage £oor (this
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produces a 30‡ head-down tilt). Forelimbs remained in contact with
the cage £oor allowing mice to move through a 360‡-circle. Mice had
at libitum access to food and water throughout the hindlimb suspen-
sion procedure.
After 2 and 8 days of treatment (overloading or unloading), mice
were anaesthetized and their soleus muscles were dissected for analy-
sis. Soleus was used because the procedure of overload applied a¡ects
especially this slow twitch muscle [17]. In a group of mice, which were
not treated, EDL (extensor digitorum longus) muscles were also an-
alyzed to perform comparison of gene expression with soleus muscles.
2.2. Electrophoretic analysis of myosin heavy chains (MHCs)
Frozen muscles were pulverized, extracted in Guba-Straub solution
and MHCs were separated by SDS-PAGE as described previously
[19]. Identi¢cation of the bands was based on their electrophoretic
mobilities. Their proportions were quanti¢ed by densitometry. All
measurements were made in duplicate for each mouse. The results
are expressed as percentage of total MHCs.
2.3. RNA isolation and Northern blot hybridization
Total RNA was isolated by the guanidium thiocyanate/cesium
chloride method [20]. Soleus or EDL muscles from ¢ve mice were
pooled. Each sample of RNA (10 Wg) was denatured in formalde-
hyde-MOPS and subjected to electrophoresis on 1.2% agarose gel.
Homogeneity of RNA loading was assessed by UV transillumination
of the gel after staining with ethidium bromide. The RNA was trans-
ferred to nylon membranes (Hybond, Amersham, Buckingham-shire,
UK) by vacuum blotting (Vacugene, Pharmacia, Uppsala, Sweden).
Levels of IGF-I, IGFBP-4 and IGFBP-5 mRNA were determined by
hybridization with speci¢c riboprobes. The 194-bp AvaII-HinfI rat
IGF-I exon 4 complementary DNA fragment was inserted into the
plasmid vector Bluescript (pBSM13+) and linearized with EcoRI. A
221-bp rat IGFBP-4 gene fragment was ligated into the plasmid vec-
tor Bluescript (pBS SK+) and linearized with BamHI. A 656-bp rat
IGFBP-5 gene fragment was ligated into the plasmid vector Bluescript
(pBS SK+) and linearized with EcoRI. The speci¢c riboprobes were
generated from linearized plasmids with uridine 5P-[32P]triphosphate
using T7 or T3 RNA polymerases.
The mRNA levels were quanti¢ed by densitometric scanning of the
hybridization signal (LKB Ultroscan XL laser densitometry; LKB,
Bromma, Sweden) using the software Gel scan (Pharmacia). All
size-class of IGF-I mRNA transcripts were pooled together. The
mRNA levels were normalized by assigning the mRNA level observed
at the day of the beginning of the experiment (day 0) an arbitrary
value of 100%.
2.4. Statistical analyses
Results were expressed as mean þ S.E.M. For RNA analysis, over-
loading experiments were performed four times (n = 4 for both control
and overload groups) and 100 mice were used. Unloading experiments
were performed ¢ve times and 140 mice were used. Di¡erences be-
tween control and overloaded or unloaded groups were compared
using a Student’s t-test and statistical signi¢cance was set at P6 0.05.
3. Results
3.1. E¡ects of overloading
3.1.1. E¡ect of overloading on muscle mass. After 8 days
of overload, a signi¢cant (15%, P6 0.05) increase in mass of
soleus muscles was observed (10.9 þ 0.5 mg for overloaded
soleus versus 9.5 þ 0.1 mg for control, n = 6). In a previous
study, we showed that 1 month of overloading induced also
in soleus muscle an increase in the ratio of type I to type II
¢bers [17].
3.1.2. E¡ect of overload on IGF-I, IGFBP-4 and IGFBP-5
gene expression.. As shown in Fig. 1, a signi¢cant increase in
IGF-I mRNA levels (60%) was found in overloaded soleus
muscles after 8 days, relative to control muscles.
Overload induced also an activation of IGFBP-4 gene ex-
pression in soleus muscles. As shown in Fig. 1, the levels of
IGFBP-4 mRNA were signi¢cantly higher (100%) than con-
trol values both after 2 days and 8 days of overload. The
e¡ect of mechanical overload on IGFBP-4 gene expression
was therefore earlier than the e¡ect on IGF-I.
In contrast to changes observed in IGF-I and IGFBP-4
mRNAs, after 2 days of overload, IGFBP-5 mRNA levels
were depressed by two thirds with respect to control values.
After 8 days, the levels of IGFBP-5 mRNA in overloaded
soleus muscles remained signi¢cantly lower than control val-
ues.
3.2. E¡ects of unloading
3.2.1. E¡ects of unloading on muscle mass and myosin heavy
chains proportions. Hindlimb unloading induced a marked
loss of soleus muscle mass. After 8 days, a 20% atrophy of
soleus muscle was observed: 9.2 þ 0.5 mg for control muscle
versus 7.3 þ 0.3 mg for unloaded soleus (n = 5, P6 0.05). The
loss of muscle mass reached 31% after 15 days: 9.3 þ 0.3 mg
for control versus 6.4 þ 0.1 mg for unloaded soleus (n = 6,
P6 0.01).
Electrophoretic analysis of MHCs showed that hindlimb
unloading for 15 days induced a shift from slow to fast phe-
notype in soleus muscles. Soleus muscles from control mice
contained high proportions of MHC1 (52%) and MHC2a
(39%) and a small proportion of MHC2x (9%). Unloading
induced a signi¢cant decrease of MHC1 (43%) (P6 0.05)
and MHC2a (24%) (P6 0.001) proportions associated with
an increased proportion of MHC2x (27%) (P6 0.001) and
an expression of MHC2b (6%). The most important change
seemed to be the shift from MHC2a to MHC2x and 2b.
3.2.2. E¡ects of unloading on IGF-I, IGFBP-4 and IGFBP-5
gene expression. As shown in Fig. 2, 2 days of unloading
induced a modest but signi¢cant decrease (30%) of IGF-I
mRNA levels in soleus muscles. This change was transient
since after 8 days of unloading the levels of IGF-I mRNA
were not di¡erent from the control value. Hindlimb unloading
had no signi¢cant e¡ect on the levels of IGFBP-4 mRNA.
In contrast to the e¡ects on IGF-I and IGFBP-4 mRNA
levels, unloading increased the amount of IGFBP-5 mRNA
by about 100%. This change in IGFBP-5 mRNA was already
conspicuous after 2 days and persisted after 8 days of unload-
ing.
3.3. Comparative gene expression of IGF-I, IGFBP-4 and
IGFBP-5 in soleus and EDL muscles
As shown in Fig. 3, soleus muscles of control animals con-
tained higher levels (35%) of IGF-I mRNA than EDL
muscles. IGFBP-4 mRNA levels were similar in both muscles.
In contrast, the level of IGFBP-5 mRNA was higher in EDL
(40%) than in soleus muscles. Thus, soleus, a slow muscle,
contained high level of IGF-I mRNA associated with low
level of IGFBP-5 mRNA whereas EDL, a fast twitch muscle,
expressed a low level of IGF-I with a high level of IGFBP-5.
4. Discussion
Our study showed for the ¢rst time that gene expression of
IGF-I and its main binding proteins in muscle, IGFBP-4 and
IGFBP-5, is acutely regulated during adaptative changes in-
duced in skeletal muscle by overloading and unloading. Given
their action on muscle cells, IGF-I and these IGFBPs prob-
ably play a role in hypertrophy and changes in phenotype
induced in vivo by overloading and unloading.
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In the present study, overloading-induced hypertrophy of
the soleus muscle is associated with increased IGF-I mRNA
levels, as previously reported [1^3]. The role of IGF-I in this
physiological response is supported by observations showing
that overexpression of IGF-I induces muscle hypertrophy
[5,6,10,11]. IGF-I is indeed believed to induce hypertrophy
by activating satellite cells, which proliferate, di¡erentiate
and fuse with pre-existing myo¢bers, maintaining the size of
the myonucleus domain [4]. Recently, it has been demon-
strated that the IGF-I-induced myo¢ber hypertrophy is medi-
ated by a calcium dependent calcineurin signalling pathway
[21,11]. It would therefore be interesting to investigate the
involvement of this pathway in hypertrophy of skeletal muscle
induced by increased load. The mechanism responsible for
increased expression of IGF-I in this model is not known. A
mechano-transduction mechanism requiring an intact cyto-
skeleton could be involved in the increase of IGF-I expression
in response to stretch and overload [22].
Fig. 1. IGF-I, IGFBP-4 and IGFBP-5 mRNAs detected by Northern blotting of 10 Wg of total RNA from control and overloaded soleus
muscles. A: Quanti¢cation of IGF-I, IGFBP-4 and IGFBP-5 mRNA levels by densitometry and expressed as percentage of the levels at day 0.
Values are means þ S.E.M.; n = 4/group. * Signi¢cantly di¡erent (P6 0.05) from control, ** (P6 0.01), *** (P6 0.001). B: Autoradiographs
showing expression of IGF-I, IGFBP-4 and IGFBP-5 mRNAs in control (CTR) at day 0, day 2 and day 8 and overloaded (OLD) soleus
muscles (day 2 and day 8).
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Reducing load on soleus muscle induces loss of muscle
mass, but no role of IGF-I in atrophy induced by unloading
has been established yet. Previous studies using di¡erent mod-
els of disuse did not report any changes in IGF-I expression
[7,18], and overexpression of IGF-I in skeletal muscle did not
prevent atrophy induced by unloading [18]. However the tran-
sient decrease of IGF-I mRNA levels induced by unloading
could be involved in myonuclear apoptosis associated with
unloading-induced atrophy, since IGF-I was shown to protect
myonuclei against apoptosis in unloaded muscles [23].
Our work is the ¢rst that demonstrated the speci¢c regula-
tion of IGFBP-4 and IGFBP-5, the main IGFBPs expressed
in skeletal muscle in mice, in response to loading or unload-
ing. The increase in IGFBP-4 mRNA associated to overload-
induced muscle hypertrophy seems paradoxical since IGFBP-
4 is generally thought to inhibit IGF-I action [24,12]. This
suggests that, in vivo, IGFBP-4 could act by a di¡erent mech-
anism on IGF-I action, or that, it prevents the proliferating
e¡ect of IGF-I on satellite cells, thus limiting the increase of
muscle mass. The early increase of IGFBP-4 could explain the
increase in IGF-I peptide independent of changes of its
mRNA observed by others in muscle subjected to exercise
[25]. In the early steps, IGFBP-4 could act by quenching cir-
culating IGF-I within the muscle before any local IGF-I ex-
pression changes. The measurement of IGF-I and IGFBP-4
proteins in overloaded muscles would con¢rm this hypothesis.
Fig. 2. IGF-I, IGFBP-4 and IGFBP-5 mRNAs detected by Northern blotting of 10 Wg of total RNA from control and unloaded soleus
muscles. A: Quanti¢cation of IGF-I, IGFBP-4 and IGFBP-5 mRNA levels by densitometry and expressed as percentage of the levels at day 0.
Values are means þ S.E.M.; n = 5/group. * Signi¢cantly di¡erent (P6 0.05) from control, ** (P6 0.01). B: Autoradiographs showing expression
of IGF-I, IGFBP-4 and IGFBP-5 mRNAs in control (CTR) at day 0, day 2 and day 8 and unloaded (ULD) soleus muscles (day 2 and
day 8).
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In contrast to IGF-I and IGFBP-4, IGFBP-5 expression is
down-regulated in overloaded muscles. This change in
IGFBP-5 expression is not compatible with its potentiating
e¡ects described in vitro [24,12]. However, in view of the
possible inhibitory e¡ect of IGFBP-5 on myoblast prolifera-
tion induced by IGF-I [16], the decrease of its gene expression
could facilitate the activating e¡ect of IGF-I on satellite cells.
In unloaded muscles, the increased expression of IGFBP-5
associated with the low level of IGF-I could promote muscle
atrophy. On the other hand, the higher levels of IGFBP-5
expression in fast muscle compared to slow muscle together
with its decrease in overloaded muscle, which undergoes fast
to slow phenotype change, suggest that IGFBP-5 could pro-
mote the fast phenotype. Alternatively, IGFBP-5 could act
independently of IGF-I by binding to its own receptor. In-
deed, IGF-I-independent e¡ects of IGFBP-5 have been
described in osteoblasts [26,27]. Binding of IGFBP-5 to the
extracellular matrix and its cleavage by speci¢c proteases
could be important factors of modulation of IGF action by
IGFBP-5.
When the e¡ects of overloading or unloading on IGF-I,
IGFBP-4 and IGFBP-5 mRNAs are taken together, it ap-
pears that IGFBP-4 and IGFBP-5 are di¡erentially regulated
by loading and that signi¢cant e¡ects on IGFBPs mRNA can
precede that on IGF-I mRNA. Thus these e¡ects are not
caused by alterations in IGF-I expression and are probably
directly induced by loading changes. This indicates that
IGFBPs are probably important in the adaptation of skeletal
muscle subjected to loading.
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